Nevada Compounder Warned for Aseptic Practices Following April Recall

Drug Industry Daily
A A
Nevada-based Green Valley Drugs, which recalled all of its sterile compounded products in April, has been warned by the FDA for a lack of sterility assurance and general quality control.

To View This Article:

Login

Subscribe To Drug Industry Daily